RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Overcoming Product Development Challenges Through Innovation and Regulation

Overcoming Product Development Challenges Through Innovation and Regulation

Posted 01 December 2008 | By

The cost of bringing a new drug to market has surpassed $1 billion (US).1 Simultaneously, pharmaceutical companies are facing budget constraints, empowered patients are demanding high-quality drugs, legislators are demanding increasing oversight to ensure patient safety, and pioneering scientific discoveries are evolving at a rapid pace.2 Faced with increasing regulatory requirements regarding patient safety and the challenges of managing global clinical trials, what can the pharmaceutical industry do to improve the efficiency and cost-effectiveness of drug discovery and development? This article reviews the changing landscape in product development and the establishment of regulatory tools for evaluating product development. It addresses some recent scientific discoveries that can help produce safer, more-effective products, as well as US Food and Drug Administration (FDA) initiatives being implemented to enable greater patient safety.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.


Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.